Inspire Medical Systems, Inc. Announces Second Quarter 2026 Financial Results, Raised 2026 Guidance, and Strategic Growth Plan

Go back to Inspire Medical Systems, Inc. Announces Second Quarter 2026 Financial Results, Raised 2026 Guidance, and Strategic Growth Plan

Inspire Medical Systems (INSP) Tops Q2 EPS by 38c, Beats on Revenue; Offers FY26 Revenue Guidance

August 3, 2026 4:05 PM EDT

Inspire Medical Systems (NYSE: INSP) reported Q2 EPS of $0.14, $0.38 better than the analyst estimate of ($0.24). Revenue for the quarter came in at $200.6 million versus the consensus estimate of $194.67 million.

GUIDANCE:

Inspire Medical Systems sees FY2026 revenue of $835-875 million, versus the... More